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G197del is the most prevalent LDL receptor (LDLR)mutation causing familial hypercholesterolemia (FH) inAshkenazi
Jew (AJ) individuals. The purpose of this study was to determine the origin, age, and population distribution of
G197del, as well as to explore environmental and genetic effects on disease expression. Index cases from Israel
( ), South Africa ( ), Russia ( ), The Netherlands ( ), and the United States ( ) werenp 46 np 24 np 7 np 1 np 1
enlisted. All trace their ancestry to Lithuania. A highly conserved haplotype (D19S221:104-D19S865:208-D19S413:
74) was identified in G197del chromosomes, suggesting the occurrence of a common founder. When two methods
were used for analysis of linkage disequilibrium (LD) between flanking polymorphic markers and the disease locus
and for the study of the decay of LD over time, the estimated age of the deletion was found to be 20 7 generations
(the 95% confidence interval is 15–26 generations), so that the most recent common ancestor of the mutation-bearing
chromosomes would date to the 14th century. This corresponds with the founding of the Jewish community of
Lithuania (1338 A.D.), as well as with the great demographic expansion of AJ individuals in eastern Europe, which
followed this settlement. The penetrance of mutation-linked severe hypercholesterolemia is high (94%of heterozygotes
have a baseline concentration of LDL cholesterol (LDL-C) that is 1160 mg/dl), and no significant differences in the
mean baseline lipid level of G197del carriers from different countries were found. Polymorphisms of apolipoprotein
E and of scavenger-receptor class B type I were observed to have minor effects on the plasma lipid profile. With
respect to determinative genetic influences on the biochemical phenotype, there is no evidence that could support the
possibility of a selective evolutionary metabolic advantage. Therefore, the founder effect in a rapidly expanding
population from a limited number of families remains a simple, parsimonious hypothesis explaining the spread of
G197del-LDLR–linked FH in AJ individuals.
Introduction
Familial hypercholesterolemia (FH; also known as “hy-
perlipoproteinemia type IIa” [MIM 143890]) is an au-
tosomal codominant disorder characterized by elevated
plasma levels of LDL cholesterol (LDL-C), tendinous
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xanthomas, corneal arcus, and premature atheroscle-
rotic coronary artery disease. FH results from mutations
at the LDL receptor (LDLR) gene, which lies on the short
arm of chromosome 19 (at 19p13.1-p13.3 [Couture et
al. 1999]). LDLR consists of a 160-kD transmembrane
glycoprotein, ubiquitously distributed and involved in
the receptor-mediated endocytosis of LDL particles from
plasma (Goldstein et al. 1985). LDLR gene spans 45 kb
and contains 18 exons encoding the six functional do-
mains of the mature protein (Su¨dhof et al. 1985). A
reduction of LDLR activity leads to diminished catab-
olism of LDL-C, resulting in elevated plasma levels of
cholesterol.
FH is one of the most common inherited metabolic
diseases, with a worldwide frequency of 1/500 for
heterozygotes and 1/1,000,000 for homozygotes (Gold-
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stein et al. 1995). More than 680 LDLR mutations have
been identified (Varret et al. 1998 [LDLR Database];
Heath et al. 2001 [The Low Density Lipoprotein Re-
ceptor (LDLR) Gene in Familial Hypercholesterole-
mia]). In relatively isolated populations—including the
French Canadians in northeastern Quebec (Moorjani et
al. 1989; Leitersdorf et al. 1990), Afrikaners in South
Africa (Steyn et al. 1989; Kotze et al. 1991), Ashkenazi
Jew (AJ) individuals (Seftel et al. 1989; Meiner et al.
1991), Druze (Landsberger et al. 1992), Christian Leb-
anese (Lehrman et al. 1987), Finns (Aalto-Setala et al.
1992; Koivisto et al. 1992), and Tunisians (Slimane et
al. 1993)—there is an increased prevalence of FH, which
reaches its height in AJ individuals (in whom the fre-
quency is 1 heterozygote per 67–69 individual [Seftel
et al. 1989]). In these populations, a small number of
LDLR mutations predominate, which either were in-
troduced at a founder time or appeared in more-recent
generations.
Wide interindividual variability in plasma lipid profile
(PLP) has been observed in FH heterozygotes, and this
feature is only partly due to mutational heterogeneity
at the LDLR locus (Moorjani et al. 1993; Bertolini et
al. 2000). Genetic and/or environmental factors are sus-
pected to influence the pathways of lipoprotein metab-
olism in patients with FH, to an extent and by a mech-
anism that remain to be ascertained.
The most prevalent FH-causing LDLR mutation in
Jews from eastern Europe (mainly Lithuania) now re-
siding in Israel is a 3-bp deletion in exon 4 of the LDLR
gene (652delGGT) (Meiner et al. 1991). The mutation
results in the deletion of Gly197 (G197del) in a highly
conserved cysteine-rich repeat of the ligand-binding do-
main of the receptor. The defective protein fails to be
transported to the Golgi complex at a normal rate
(LDLR mutational functional class IIb [Hobbs et al.
1990]), most likely because of improper folding.
G197del was originally described in a patient homo-
zygous for FH who was from the United States (Hobbs
et al. 1990). It was also found in eight South African
Jews (Meiner et al. 1991), six unrelated Jewish families
from the United Kingdom (Gudnason et al. 1993), one
German (Geisel et al. 1995), and seven Jews with FH
who were from St. Petersburg (Mandelshtam et al.
1998). In this article, we address the question as to
whether this mutation had a single origin and, if so,
when and where the mutational event occurred. To this
end, we used the observed distribution of allelic variants
of three flanking short tandem-repeat (STR) markers
(D19S221, D19S865, and D19S413) on mutant and
control chromosomes, to estimate the age of the mu-
tation by linkage disequilibrium (LD) analysis and by
modeling LD’s decay over time.
Among disease in AJ individuals, FH has received
scarce attention from population geneticists. This is due
to its allelic heterogeneity at the LDLR locus and to the
consequent difficulty in enlisting a number of genetically
homogeneous independent cases (to date, eight different
mutations have been detected in families with FH that
are of AJ origin [Varret et al. 1998: LDLR Database).
However, the dominant inheritance pattern of FH, an
infrequent phenomenon among disorders in AJ individ-
uals, supplies a novel opportunity to address the intrigu-
ing issue of why such an array of genetic disease has a
high frequency in the AJ population. Provided that their
penetrance is high even in heterozygotes and that mod-
ifying genetic factors do not influence, in a considerable
way, the expressed phenotypes, dominant mutations are
exposed to direct selection uniformly within and among
populations, and the hypothesis of carrier advantage
does not apply in this case. In an attempt to exclude
major interference that polymorphisms known to affect
cholesterol metabolism in other circumstances might
have on the G197del-linked biochemical phenotype, the
influences that common genotypes of apolipoprotein E
(ApoE; Hagberg et al. 2000) and of scavenger receptor
class B type I (SR-BI; Iwaki et al. 1999) have on the
baseline PLP of index cases from different countries
were investigated. The results support the eligibility of
this FH founder mutation for a straightforward model
for studying the genetic history (and the underlying
mechanisms) that have yielded the spectrum of inherited
disorders observed at remarkable frequency in the AJ
population today.
Subjects, Material, and Methods
Families and Subjects
A total of 46 families from Israel, 24 families from
South Africa, 7 families from Russia, 1 family from The
Netherlands, and 1 family from United States were col-
lected by an international cooperative effort aimed at
comparing the FH phenotypic variance among geo-
graphic areas, to evaluate disease penetrance and the
effects that environmental and modifying genetic factors
have on the biochemical manifestations of the disorder.
Written informed consent was obtained prior to the fam-
ilies’ participation, under protocols approved by the lo-
cal institutional review boards. Index cases (table 1) were
patients with marked hypercholesterolemia and a doc-
umented history of FH in their families and were carriers
of G197del in the LDLR gene (Meiner et al. 1991). In-
formation on the geographic location of current and
ancestral settlements of families was obtained by asking
for the birthplace of the proband and of his or her grand-
parents. Detailed interviews excluded cases from related
families. Most, if not all, index cases are of AJ origin or
of mixed AJ–non-AJ origin. Of the 46 patients residing
in Israel, one (index case 430-002) belongs to an Iraqi
Table 1
Location, Ancestry, Sex, Age, ApoE and SR-BI Polymorphisms, and PLP of Patients with G197del LDLR
FAMILY LOCATION
AND INDEX CASE
(SEX/AGE [YEARS]) ANCESTRAL ORIGINa
POLYMORPHISMSb
PLP
(mg/dl)
ApoEb
(e)
SR-BIc
(C/T) TC TG HDL-C LDL-C
Israel:
302-001 (M/48) AJ (E) 2,3 C,C 500 … … …
303-006 (F/62) AJ (E) 3,3 C,C 286 67 46 227
307-004 (M/49) AJ (E) 3,3 C,C 363 182 38 289
314-003 (M/41) AJ (E) 3,3 C,T 439 125 38 375
339-001 (F/57) AJ (E) 3,3 C,T 367 177 28 304
340-001 (M/31) AJ (E) 3,3 C,C 600 … … …
341-002 (M/11) Unknown 3,3 C,C 425 116 61 341
342-001 (F/60) Unknown 3,3 C,T 283 102 51 212
343-001 (M/76) AJ (E) 3,4 C,T 237 175 35 167
344-001 (F/55) AJ (E) 3,4 C,T 458 232 31 381
357-001 (F/26) AJ (E) 3,4 T,T 275 59 40 223
358-001 (F/34) AJ (E) 3,3 C,T 320 … … …
359-001 (F/23) AJ (US) 2,4 C,T 420 … … …
382-001 (F/20) AJ (E) 2,3 T,T 380 124 61 294
383-001 (F/19) Unknown 3,3 T,T 450 … … …
384-001 (M/10) Unknown 2,3 C,T 300 … … …
388-001 (F/58) AJ (E) 3,3 C,T 348 150 68 250
402-001 (F/33) AJ (E) 3,3 T,T 350 178 51 263
404-001 (M/32) AJ (PL) 3,4 C,C 300 91 34 248
405-001 (F/66) AJ (E) 3,3 C,C 493 164 … …
406-001 (F/56) AJ (E) 3,4 C,C 483 162 44 407
413-001 (F/57) AJ (E) 3,3 C,C 238 142 36 174
421-001 (M/61) Unknown 3,3 T,T 376 100 32 324
426-001 (M/27) AJ (E) 3,3 C,C 403 157 39 332
430-002 (F/9) IJ-AJ (mx) 3,3 T,T 338 40 51 279
453-001 (F/40) AJ (E) 4,4 T,T 245 67 39 193
463-001 (M/27) AJ (E) 3,3 C,C 278 83 35 223
494-001 (F/61) AJ (E) 3,3 T,T 464 133 78 359
496-001 (F/34) AJ (E) 3,3 C,T 402 114 41 338
503-001 (F/74) AJ (E) 2,4 C,C 360 … … …
549-001 (F/36) AJ (E) 3,3 T,C 379 97 53 306
558-002 (F/15) AJ (E) 3,3 C,C 284 71 41 229
560-001 (F/54) Unknown 3,3 C,C 435 326 52 319
569-001 (F/38) Unknown 3,3 T,T 388 166 60 295
577-001 (F/72) AJ (E) 3,3 C,C 500 … … …
H-009 (M/39) AJ (E) 3,3 T,T 472 114 36 413
H-011 (F/53) AJ (E) 3,3 C,C 515 373 28 412
T-007 (M/44) AJ (E) 3,3 C,C 231 69 35 182
T-010 (M/40) AJ (E) 3,3 T,T 217 111 26 169
T-014 (F/30) AJ (E) 3,3 T,T 296 124 37 234
T-026 (F/42) AJ (E) 3,3 C,C 275 86 53 205
T-028 (M/40) AJ (E) 3,3 C,C 292 126 30 237
T-029 (M/43) AJ (E) 2,3 C,C 241 61 31 198
T-032 (F/49) AJ (E) 3,3 C,C 357 174 35 287
T-035 (M/36) AJ (E) 3,3 C,C 281 101 65 196
T-040 (F/65) Unknown 3,3 … 331 188 42 252
Mean  SD for Israeld 362.5  91.6 134.9  67.7 43.3  12.5 274.0  72.0
South Africa:
107 (M/49) Coloured (mx) 3,3 C,C 398 212 35 320
181 (F/33) White (E) 3,4 … 358 62 58 289
238 (F/48) White (E) 3,3 C,C 490 328 50 375
442 (M/30) AJ (E) 3,4 … 390 301 35 293
523 (F/35) White (E) 2,2 T,T 289 80 62 212
636 (F/48) White (E) 3,4 C,C 289 150 31 231
642 (F/71) White (E) 3,3 C,T 472 124 35 414
651 (F/58) White (E) 2,3 … 445 283 43 344
716 (F/49) AJ (E) 2,3 C,T 317 71 62 244
(continued)
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Table 1 (continued)
FAMILY LOCATION
AND INDEX CASE
(SEX/AGE [YEARS]) ANCESTRAL ORIGINa
POLYMORPHISMSb
PLP
(mg/dl)
ApoEb
(e)
SR-BIc
(C/T) TC TG HDL-C LDL-C
922 (F/19) Coloured (mx) 3,3 C,C 428 106 43 363
1101 (M/31) AJ (D) 3,3 T,C 270 204 43 183
1102 (F/51) AJ (LT) 3,3 … 542 133 54 460
1103 (M/48) AJ (LT) 3,3 … 456 274 35 367
1104 (F/44) AJ (Russia) 3,3 C,C 398 141 23 333
1105 (M/36) AJ (LT) 3,3 T,T 401 345 54 272
1106 (F/73) AJ (UK) 3,3 … 476 186 42 395
1107 (M/48) AJ (LT) 3,4 T,C 321 97 35 267
2584 (F/24) White (E) 3,3 … 294 124 54 216
2611 (F/18) White (E) 2,3 C,T 391 71 50 328
4084 (M/22) White (E) 3,3 T,T 452 230 27 378
A104 Hb (F/41) AJ (E) 3,3 T,T 231 45 42 181
A129 CD (F/53) AJ (E) 3,3 C,C 301 53 58 231
D185 NL (F/12) AJ (E) 3,3 T,T 385 85 30 339
D729/91 (F/61) Coloured … … 564 245 32 484
Mean  SD for South Africae 389.9  88.2 164.6  93.3 43.0  11.5 313.3  83.5
Russia:
50-001 (M/47) AJ 2,3 C,C 265 312 19 184
51-001 (F/56) AJ 2,3 T,C 492 105 52 419
52-001 (M/37) AJ 2,3 T,C 362 188 38 286
53-003 (M/29) AJ 3,3 … 286 134 58 201
54-003 (F/33) AJ 2,3 T,C 319 103 60 238
55-001 (M/44) AJ 2,3 T,C 500 285 64 379
56-001 (M/38) AJ … … 408 85 49 342
Mean  SD for Russiaf 376.0  94.6 173.1  92.1 48.6  15.6 292.7  90.5
Onb-2341 (F/69) AJ 3,4 C,C 366 68 71 289
Piscataway (M/9) AJ (E) … … 870 … … …
a D p German; E p European; IJ p Iraqi Jew; LT p Lithuanian; NL p Dutch; PL p Polish; UK p British; US p North American; mx
p mixed.
b 2 p e2; 3 p e3; 4 p e4.
c In exon 8.
d Mean age  SD p 42.5  17.4 ( ).np 46
e Mean age  SD p 41.8  16.2 ( ).np 24
f Mean age  SD p 40.6  9.1 ( ).np 7
Jewish family whose pedigree includes a marriage be-
tween one ancestor and an AJ women. Of the three
nonwhite patients (“coloured” population) residing in
South Africa, two are known to have AJ-mixed ancestry
(Loubser et al. 1999). The case from The Netherlands
is Christian, whereas the patient from the United States
(Piscataway, NJ) is of AJ origin (Poland) and represents
the only subject homozygous for the 197del LDLR
mutation.
A cohort of 45 control AJ individuals from Israel,
providing 90 normal independent chromosomes, was
used for estimating the frequencies of alleles at marker
loci. Control subjects included family members and un-
related individuals.
Biochemical Determinations
PLPs of the index cases are reported in table 1. Blood
was collected in tubes containing EDTA, after an over-
night fast and before any hypolipidemic drug or dietary
treatment. By means of commercially available diag-
nostic kits, plasma total cholesterol (TC), triglycerides
(TG), and LDL cholesterol (HDL-C) were analyzed in
local laboratories, by standardized enzymatic methods,
either directly (in the case of TC and TG) or in the
supernatant after chemical precipitation of ApoB-con-
taining lipoproteins (in the case of HDL-C). LDL-C was
calculated by means of the Friedewald et al. (1972)
formula.
Genotyping and Haplotyping
DNA was isolated from peripheral blood leukocytes,
by standard procedures. Chromosomes were screened
for the G197del LDLR mutation, by PCR amplification
and heteroduplex analysis as described elsewhere (Mei-
ner et al. 1991). With one exception (the individual from
Piscataway, NJ), all patients were heterozygous for the
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mutation. Three polymorphic markers (The Genome
Database accession number; repeat, amplimer) were
used for genotyping disease and normal chromosomes:
D19S221 (188431; (CA)n, AFM224ye9), D19S865
(602894; (CA)n, AFMa107xc9), and D19S413 (199839;
(CA)n, AFM292wd9). Fluorescently labeled primers
(ABI-PRISM [F]dUTPs) for D19S221 and D19S865
were purchased from PE Applied Biosystems. PCR con-
ditions were according to the manufacturer’s proto-
cols. Fluorescently labeled primers for D19S413 were
5′-GTTTATTTTAAATGCTCTTACCACA-3′ (forward)
and 5′-CCATCAACTCACCTACTTATCGT-3′ (re-
verse). PCR was performed under the following condi-
tion: 95C for 12 min; followed by 10 cycles of 94C
for 15 s, 55C for 15 s, and 72C for 30 s; 20 cycles of
89C for 15 s, 55C for 15 s, and 72C for 30 s; and a
final extension at 72C for 10 min. The reaction mixture
contained 1.2 ml of DNA (50 ng/ml), 1 ml each of the
forward and reverse primers (10 pmol/ml), 2.8 ml of
double-distilled water (DDW), and 9 ml of ABI-PRISM
PCR premix solution. Allele sizes were determined on
an ABI 310 semiautomated sequencer, by comparison
with size standards (400 HD Rox GENESCAN soft-
ware). Haplotype data were obtained either from infor-
mative pedigrees (via cosegregation of microsatellite al-
leles) or via homozygosity at marker loci.
ApoE Restriction Isotyping
Restriction isotyping (restriction-enzyme isoform ge-
notyping) has been used for typing common ApoE alleles
(e2–e4) by means of a modified version of the procedure
described by Hixson and Vernier (1990). The method
relies on PCR amplification of ApoE gene sequences that
encompass amino acid positions 112 and 158, followed
by CfoI cleavage of amplified DNA and separation of
the resulting digestion fragments by gel electrophoresis.
The following primers were used: 5′-GAGAAGCT-
TGCGGCGCAGGCCCGGCTGGGCGCG-3′ (forward)
and 5′-TGAAGCTTCGCTCGGCGCCCTCGCGGGC-
CCGGG-3′ (reverse). PCR was performed under the
following conditions: 94C for 5 min, followed by 30
cycles of 94C for 1.5 min and 72C for 3 min. The PCR
mixture contained 23 ml of each dNTP (10 mM), 1.14
ml of dimethylsulfoxide, 190 ml of NH4SO4 (1 M), 600
ml of Tris-HCl (1 M; pH 9), 160 ml of Tris-HCl (1 M;
pH 8), 76 ml of MgCl2 (1 M), 140 ml of DTT (1 M),
193 ml of BSA, 7.44 ml of DDW, 2 ml of DNA (50 ng/
ml), and 0.2 ml of Taq DNA polymerase (5 U/ml). After
amplification, 1 ml of CfoI (10 U/ml; Boehringer-Mann-
heim) was added to 15 ml of PCR mixture, according
the manufacturer’s instructions. The restriction mixture
was left for 3 h at 37C, and the product was separated
on 8% polyacrylamide gel and was visualized by ethi-
dium bromide staining. The sizes of CfoI fragments were
estimated by comparison with markers of known size.
Analysis of SR-BI Polymorphisms
SNP C/T at codon 350 in exon 8 of the gene encoding
for the SR-BI was detected by HaeIII (Acton et al. 1999).
The following primers were employed: 5′-CTTG-
TTTCTCTCCCATCCTCACTTCCTCAAGGC-3′ (for-
ward) and 5′-CACCACCCCAGCCCACAGCAGC-3′
(reverse). PCR conditions were 94C for 5 min, followed
by 30 cycles of 94C for 1 min, 68C for 1 min, and
75C for 1 min. The reaction mixture contained 0.2 ml
of a-[32P]dCTP (5 Ci/ml), 1 ml of each dNTP (10 mM),
1 ml each of the forward and reverse primers (optical
density 5), 0.2 ml of Taq DNA polymerase (5 U/ml), 2
ml of PCR buffer (Roche Diagnostics), and 13.6 ml of
DDW. Digestion with HaeIII (Boehringer Mannheim)
was performed at 37C for 2 h, according to the man-
ufacturers’ instructions. The product (20 ml) was sepa-
rated on 8% polyacrylamide gel and was visualized by
overnight exposure to a film plate. The sizes of HaeIII
fragments were estimated by comparison with markers
of known size.
LD Analysis
Allele-frequency distributions in disease and control
AJ chromosomes were compared by evaluating the dif-
ference in proportions (Daniel 1995). The cohorts of
mutation-bearing and normal chromosomes were con-
sidered as two independent random samples—of size nD
and nN, respectively—that are drawn from two popu-
lations of dichotomous variables; then, the proportion
of observations with the characteristics of interest in the
two populations are pD and pN (the frequencies of a
marker’s allele on disease-mutation–bearing and normal
chromosomes, respectively), and the distribution of the
difference between sample proportions is approximately
normal, with normal mean equal to pD  pN and with
variance
p (1 p ) p (1 p )D D N N2j p  ,ˆ ˆp pD N n nD N
when nD and nN are large. According to standard bio-
metrics, nD and nN can be considered sufficiently large
when nDpD, nNpN, nD(1pD), and nN(1pN) are all 15
and the population proportions are not too close to 0
or 1. For the area under the curve of the standard normal
distribution (one sided, since each allele was tested for
evidence of increased frequency on mutation-bearing
chromosomes), significance of the observed difference
can be derived by the statistic . Underzp (p  p )/jD N
these circumstances, it is also possible to compute a
% interval for the estimated difference,100(1 a)
. Theoretically, in the event2a(p  p ) (z # j )ˆ ˆD N 1 p pD N2
that the constraint indicated above is not met (frequency
5), a correction should be introduced; however, con-
ditions requiring the correction are also those that rec-
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ommend against the use of the corresponding alleles for
LD analysis. Similarly, nonsymmetric variance should be
used for proportions close to 0 or 1, and, again, these
circumstances do not recommend the allele as a candi-
date for LD analysis. Consequently, whenever the sample
of chromosomes is reasonably large, the general formula
can be applied. Since more than one allele was tested at
each marker locus, a Bonferroni correction was applied
by multiplication of the nominal significance level (P)
by the number of alleles tested.
The measure of LD, d, between each marker locus and
G197del was calculated, according to the method of
Bengtsson and Thomson (1981), as (pDpN)/(1pN). Re-
cently, Diaz et al. (2000) suggested that a confidence
interval (CI) for d can be conveniently calculated under
the assumption of independence for the sampled chro-
mosomes. Since is a functiondp 1 (1 p )/(1 p )D N
of the ratio of two independent random variables, the
variance of d can be approximated by
21 jp2 2 2 D[ ]var(d)p j j  (1 p )  ,p p D4 2N D(1 p ) (1 p )N N
(1)
where and2 2j p [p (1 p )]/n j p [p (1p N N N p DN D
. An appropriate CI (i.e., 90%) of d can then bep )]/nD D
obtained as , where .2d 1.64j j p var(d)d d
Recombination Fraction (v)
The sex-averaged v between each polymorphic marker
and LDLR gene was obtained from Couture et al. (1999).
The v’s between D19S221, D19S413, and the LDLR locus
were also estimated on the basis of physical distances (in
Mb) available from the Metric Physical Map (Maps of
Human Chromosome 19). The genetic-distance:physical-
distance ratio assumed for chromosome 19p13.1-13.2
(1.9 cM/Mb) is according to Mohrenweiser et al. (1998,
fig. 2A). To calculate the genetic distance of D19S839, its
radiation-hybrid distance (in cR10,000) from D19S413
(GeneMap’99) was converted into centimorgans, by use
of a ratio of 0.2 Mb/cR10,000. Kosambi’s function, vp
, was applied to0.5[exp (w/25) 1]/[exp (w/25) 1]
convert genetic map distance, w (in cM), into v.
Age Estimation
To yield an appropriate estimate of the age of the
mutation, two different algorithms were used, both of
which are based on the “genetic clock” equation (La-
buda et al. 1997), , relating the time (in gen-lnPp vg
erations [g]) back to the most recent common ancestor
of mutant chromosomes, the frequency of recombina-
tion between the disease locus and the marker (i.e., v),
and the probability that a marker’s allele on a disease
chromosome is the ancestral one (P). An unbiased es-
timate of P is the proportion of observed haplotypes
that are ancestral. The first method relies on the algo-
rithm of Risch et al. (1995),
log d
gp . (2)
log (1 v)
The second method (Reich and Goldstein 1999) gen-
erates a Markov transition matrix (K), which gives the
probabilities that, in a single generation, any one hap-
lotype will be transformed into any other one. K is cal-
culated as the weighted sum of matrices corresponding
to recombination (R), mutation (M), and no event oc-
curring (I):
Kp vR mM (1 v m)I , (3)
where m is the frequency of mutation at the marker
locus. Matrix R has the elements , ,R p p R p p11 N 12 N
, and . If a stepwise mutationR p 1 p R p 1 p21 N 22 N
model for microsatellites (Goldstein and Pollock 1997)
and a distribution of marker allele sizes on disease chro-
mosomes that matches that seen in the control popu-
lation are assumed, then M has the elements ,M p 011
, , and , where f is theM p f/2 M p 1 M p 1 (f/2)12 21 22
frequency of all one-mutant neighbors of the ancestral
allele in the control population. With the parameters of
K specified (under the assumption of formp .00056
dinucleotide repeats [Weber and Wong 1993]), the num-
ber of generations g that have passed since the foun-
dation event is estimated by multiplication of the state
vector (q, ) by K iteratively until the observed pro-1 q
portion of ancestral haplotypes is reached ( ). It-q ≈ pD
eration begins at a frequency vector of (1,0), correspond-
ing to the archetypal condition of only ancestral
haplotype. The number of times that K is multiplied
yields the estimate of g (Reich and Goldstein 1999).
The setting of the genetic clock according to the ap-
proach of Luria and Delbru¨ck (1943), which takes into
account the population growth rate, was performed by
correction of the estimated age, as follows:
g p g g , (4)c 0
with
1
g p  ln (vf ) , (5)0 dd
fD being equal to ), where d is the population
d de /(e  1
growth rate (for small d values, ) (Labuda et al.f ≈ 1/dd
1996).
Age estimates based on each marker’s data have been
analyzed by the conventional procedures used for par-
ametric variables, by the SPSS program, version 9 (SPSS).
A minimum CI for the age estimates was calculated by
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Table 2
Frequencies of Alleles at Marker Loci D19S221,
D19S865, and D19S413, in G197del-Mutation–
Bearing and Control Chromosomes
ALLELE SIZE
(bp)
FREQUENCY IN CHROMOSOMES
Control G197del
D19S221:a
88 .022 …
90 .011 …
92 .022 …
94 .067 …
96 .122 …
98 .033 .038
100 .156 …
102 .111 .038
104 .400 .885
106 .056 .038
D19S865:b
200 .089 .027
202 .200 .054
204 .078 .081
206 .078 .027
208 .222 .703
210 .156 .081
212 .167 .027
D19S413:c
64 .011 …
66 .011 …
68 .022 …
70 .089 .030
72 .111 …
74 .311 .909
76 .178 .030
78 .111 …
80 .100 .030
82 .067 …
a For control chromosomes, ; for G197delnp 90
chromosomes, .np 26
b For control chromosomes, ; for G197delnp 90
chromosomes, .np 37
c For control chromosomes, ; for G197delnp 90
chromosomes, .np 33
means of equation (2), with the minimum CI for d (Diaz
et al. 2000).
Statistical Analysis
Statistical analysis was performed by the SPSS pro-
gram, version 9. Before comparison of subgroups of
G197del carriers according to country of residence, PLPs
were adjusted for sex and age, by linear multiple-re-
gression analysis. The allele distribution for ApoE and
SR-BI polymorphisms was determined by gene counting.
The impact of ApoE and SR-BI genotype on PLP of
carriers was tested by application of variance-covariance
analysis to each plasma-lipid variable, with genotype
subgroup as fixed factor, sex as random factor, and age
as covariate. The general linear model (multivariate
analysis) failed to provide more information. The level
of statistical significance was set at .Pp .05
Results
LD Analysis and Age Estimation
Genomic DNA samples from 79 index cases with FH
(table 1) and from additional family members (when
available) were typed for the G197del LDLR mutation
and for alleles at three flanking polymorphic markers
(D19S221, D19S865, and D19S413), to determine
whether patients from unrelated families and different
locations harbored the same mutation identical by de-
scent. A putative ancestral three-allele haplotype
(D19S221:104-D19S865:208-D19S413:74) was identi-
fied in G197del chromosomes from 54 (68%) of the
index cases, either as certain (when phase could be un-
ambiguously determined) or as most likely (when gen-
otypes were consistent with the conserved haplotype).
As well, five related haplotypes (104-208-70, 104-202-
74, 104-210-74, 98-208-74, and 106-208-74) were
found in 14 (18%) of the index cases, either as certain
or as most likely. Since it is only at one marker that these
haplotypes vary from the ancestral 104-208-74 haplo-
type, it is likely that they derived from the latter by either
recombination or mutation.
We analyzed the frequencies of STR alleles associated
with G197del and compared them with the correspond-
ing allele frequencies in the background AJ population
(table 2). On G197del chromosomes, alleles at each
marker locus were counted only when the marker’s hap-
lotype was known for certain (phased chromosomes or
locus homozygosity). When data from the certain hap-
lotypes and from the most likely haplotypes were pooled,
the resulting allele frequencies proved to be similar to
those reported in table 2 ( , .67, and .86 forp p .83D
alleles 104, 208, and 74, respectively). The three alleles
defining the ancestral 104-208-74 haplotype on the
G197del chromosomes occurred at significantly (cor-
rected ) increased frequency (table 3). In lightP ! .0001
of the frequencies of the same alleles on normal chro-
mosomes ( , .222, and .311, respectively), thep p .400N
probability of finding the ancestral haplotype identical
by state in the general AJ population is low (i.e.,
). LD index values show a higher degree of22.8# 10
allelic excess at D19S221 (allele 104, [90%CIdp .808
.635–.981]) and D19S413 (allele 74, [90%CIdp .868
.748–.988]) than at D19S865 (allele 208, dp .618
[90%CI .455–.780]).
The presence of detectable LD at markers flanking the
LDLR locus, as well as the availability of defined map
distances for each of them, allowed the estimation of
the coalescence time for G197del chromosomes. To ac-
count for the uncertainty inherent in the mapping of
tightly linked loci, genetic distances between markers
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Table 3
LD between the G197del LDLR Mutation and Chromosome 19p13 Flanking Markers, as Evidenced by Allelic Excess
MARKER
MAXIMUM
HETEROZYGOSITYa
ALLELE
SIZE
(bp)
HAPLOTYPE DATA
pD pN
Estimate of
Difference in Proportions LDb
Mean  SE (95%CI) Pc d (vard) 90% CI
D19S221 .87 104 .885 (23/26) .400 (36/90) .485  .081 (.325–.644) !.0001 .808 (.011) .635–.981
D19S865 .89 208 .703 (26/37) .222 (20/90) .480  .087 (.310–.651) !.0001 .618 (.010) .455–.780
D19S413 .78 74 .909 (30/33) .311 (28/90) .598  .070 (.461–.635) !.0001 .868 (.005) .748–.988
a Source: Centre d’E´tude du Polymorphisme Humain.
b Calculated according to the method of Bengtsson and Thomson (1981): .dp (p  p )/(1 p )D N N
c Corrected according to the Bonferroni method.
d Obtained by use of equation (1).
and the LDLR locus were obtained from two sources:
directly, from sex-averaged v values (Couture et al.
1999), and indirectly (via genetic to physical distance
ratio), from physical maps publicly available from the
Lawrence Livermore National Laboratory Human Ge-
nome Center (see its Maps of Human Chromosome 19
website) and GeneMap’99. The two v values were in
excellent agreement for D19S865 ( and .026,vp .025
respectively), whereas a significant difference was ob-
served for D19S221 and D19S413 (the difference in v
values was .006 and .008, respectively). This minor in-
consistency is not uncommon when a comparison is
made between genetic distances from different sources
(e.g., see Colombo and Carobene 2000; Diaz et al.
2000).
Age was estimated in two ways. First, we applied the
algorithm of Risch et al. (1995), a method for estimating
the coalescent time of mutant chromosomes that focuses
on the proportion of lineages not having undergone ei-
ther a mutation or a recombination event (eq. [5]). The
age of the most recent common ancestor (expressed in
terms of g) is expressed as a function of v and d, which
is a measure of LD (Bengtsson and Thomson 1981) (also
known as “Pexcess” [Lehesjoki et al. 1993]). Because d is
a function of two conditional probabilities—that is, pD
and pN—it could be estimated from case-control data
obtained from separate samples of independent muta-
tion-bearing and normal chromosomes (table 2). Using
a simple general model, Lazzeroni (1998) recently
showed how d can be interpreted in terms of identity-
by-descent probabilities. To take into account the pres-
ence of a proportion of nonancestral alleles among the
mutation-bearing chromosomes, a second approach was
undertaken, which models the regeneration of the an-
cestral haplotype by the recombination process. This can
be done in a number of ways. We chose the Markov
transition-matrix method of Reich and Goldstein
(1999), for its flexibility. Under this model, it was
straightforward to include both recombination and mu-
tation data for each marker. As suggested by Goldstein
et al. (1999), for simplicity we assumed a strict stepwise
mutation model for STRs (Goldstein and Pollock 1997).
Table 4 shows the age of origin of the G197del LDLR
mutation, as estimated by the two methods. The age
estimate varies considerably from marker to marker.
This disappointing feature of the results is probably due
both to sampling variation in allele frequencies at dif-
ferent loci and to the uncertainty linked to the calcu-
lation of the v values and is common to mutation dating
by LD analysis (Guo and Xiong 1997). The mean 
SD overall age estimate is g (95%CI11.8 6.4
6.7–16.9 g) according to the Risch et al. (1995) algo-
rithm and is g (95%CI 6.4–16.2 g) according11.3 6.1
to the Reich and Goldstein (1999) iterative method.
Since the age estimate provided by LD analysis at each
marker locus is based on two v values, it is questionable
whether the six available age estimates are really inde-
pendent of each other. If we consider the pair of v values
as nonindependent variables, then the mean age esti-
mates obtained by the two methods remain unchanged
and a small change is observed in their SD, whereas the
corresponding 95%CIs increase remarkably (to
4.0–19.6 and 3.6–19.0, respectively).
It is possible that the age estimated by the two methods
is an underestimate: attention has been directed, by sev-
eral previous reports, to the fact that, when applied to
growing populations, the genetic clock ticks more slowly
than expected (Luria and Delbru¨ck 1943; Ha¨stbacka et
al. 1992; Kaplan et al. 1995; Labuda et al. 1996). This
was originally described for mutations in growing bac-
terial cultures and can be corrected as proposed by Luria
and Delbru¨ck (1943). In human population genetics, this
correction was first applied in an LD fine-mapping study
that used Finnish-population haplotype data to study
the diastrophic dysplasia gene (Ha¨stbacka et al. 1992).
When genetic distances are available and the unknown
parameter is the age of the founder effect, this approach
(Labuda et al. 1996; Colombo 2000) sets the genetic
clock by introducing a correction factor, g0 (eq. [4]).
Given the v between each marker and the LDLR locus,
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Table 4
Estimation of Age of the G197del Mutation in the LDLR Gene Causing FH in AJ Individuals
MARKER
OR ALLELE
LDa
(d)
ESTIMATED AGEb
DISTANCE FROM LDLR
g0
Method 1 Method 2
Megabases Centimorgans v g1 g1c g2 g2c
D19S221 .015c .808 8.2 14.1 22.3 13 21.2
104 1.1 2.1 .021d .808 7.4 10.0 17.4 10 17.4
D19S865 .025c .618 6.9 19.0 25.9 18 24.9
208 2.6 .026e .618 6.8 18.3 25.1 18 24.8
D19S413 .026c .868 6.8 5.4 12.2 5 11.8
74 1.8 3.4 .034d .868 6.2 4.1 10.3 4 10.2
a g1 is the age calculated by use of equation (2) (Risch et al. 1995); g2 is the age obtained according to
the iterative procedure of Reich and Goldstein (1999), when equation (3) is used; g1c and g2c were obtained
from equation (4). Iterations stopped at an average distance of from the corresponding pD value.
35# 10
g0 was calculated by use of equation (5), under the assumptions and .dp .4 f p 1/dd
b Calculated according to the method of Bengtsson and Thomson (1981): .dp (p  p )/(1 p )D N N
c Sex averaged, from Couture et al. (1999).
d Estimated on the basis of physical distance (in Mb), by use of the conversion factor 1.9 Mb/cM and
Kosambi’s map function.
e Estimated by use of radiation-hybrid distance (in cR10,000) of D19S865 from D19S413 (conversion factor
0.2 Mb/cR10,000) and Kosambi’s map function.
and under the assumption that is the mean AJdp .4
population growth rate (Risch et al. 1995; Labuda et al.
1997), the parameter g0 was calculated (table 4) by equa-
tion (5). The mean  SD overall estimates corrected for
population growth according to the Luria-Delbru¨ck ap-
proach are g (95%CI 13.6–24.2 g) and18.9 6.6
g (95%CI 13.3–23.5 g), for the ages cal-18.4 6.4
culated according to the methods of Risch et al. (1995)
and Reich and Goldstein (1999), respectively. However,
a common source of uncertainty in the Luria-Delbru¨ck
correction of the genetic clock is the value of d. To ac-
count for the variability of d,we calculated the geometric
mean  SD of the corrected ages estimated with the
extreme values of a reasonable range of AJ population
growth rate (.1–.8), g (95%CI 14.9–26.3 g)20.6 7.1
and g (95%CI 14.6–25.6 g), respectively.20.1 6.9
Thus, according to the results from the two methods
used and with consideration of v values (from which the
results were obtained) as independent estimates, the age
of the most recent common ancestor of G197del chro-
mosomes can be estimated as 20 g (95%CI 15–26 g).
The minimum CIs for the estimated age can also be
calculated with reference to the variance of the LD index,
by use of equation (2), with the approximate CI for d
being derived from var(d), obtained by equation (1).
When the mean v values for each marker are used, the
minimum CIs are 9–33 g (for D19S221), 16–37 g (for
D19S865), and 7–16 g (for D19S413). The median value
for g (corrected for population growth at ) is 21.dp .4
As recently pointed out by Diaz et al. (2000), it is difficult
to calculate a “true” CI for the estimate of g, because,
under the assumption of LD, the mutation-bearing chro-
mosomes are not independent (Risch et al. 1995; Ran-
nala and Slatkin 1998). For convenience, we have been
using the term “confidence interval” (here denoted as
“CI”), but it is important to appreciate that these cal-
culations are meant to be illustrative of how an estimated
demographic parameter (i.e., d) influences confidence
and that they cannot be construed as producing the for-
mal CI. Assumptions concerning the population growth
rate strongly influence the degree of mutation-bearing
chromosomes’ nonindependence and, hence, the CI.
Rapid demographic expansion soon after the mutational
event (or a bottleneck) leads to greater statistical inde-
pendence and narrower CIs, whereas a flat demographic
curve leads to less independence and broader CIs (Ran-
nala and Slatkin 1998; Goldstein et al. 1999). Thus, the
minimum CIs for g calculated by means of the var(d)
are not independent of the CI obtained with the extreme
values of a reasonable CI for AJ population growth rate,
and it is not evident which of the two CIs reflects more
reliably the “true” CI. Further investigations will be nec-
essary to refine an appropriate algorithm to solve the CI
problem; however, it is questionable whether its imple-
mentation will be either easy or of great benefit (Diaz
et al. 2000).
Genotype and Biochemical Phenotype
Despite remarkable changes in climate and diet, no
significative difference in PLP, adjusted for sex and age,
was observed among index cases clustered according to
the three main countries of residence (Israel, South Af-
rica, and Russia) (table 1).
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Table 5
PLP Traits According to the Absence or Presence of ApoE Allele e2 and e3
PLP Trait
ApoE e2 ApoE e4
Mean  SD Concentration
(mg/dl)
P
Mean  SD Concentration
(mg/dl)
PAbsent Present Absent Present
TC 368.5  90.3 ( )np 60 372.1  85.4 ( )np 15 .814 373.9  90.1 ( )np 63 344.7  81.0 ( )np 12 .241
TG 147.8  77.6 ( )np 56 153.0  96.8 ( )np 11 .705a 150.2  80.8 ( )np 57 139.6  80.6 ( )np 10 .554b
HDL-C 42.8  11.8 ( )np 55 49.3  14.9 ( )np 11 .122c 44.8  12.9 ( )np 56 38.2  8.0 ( )np 10 .138c
LDL-C 286.4  76.8 ( )np 55 284.2  76.9 ( )np 11 .956 288.9  76.5 ( )np 56 269.9  76.6 ( )np 10 .446
a For age, .Pp .017
b For age, .Pp .016
c For sex, .Pp .012
Analysis of ApoE allele frequencies in our sample of
patients with FH who have G197del yielded e2p
, , and (for counted alleles.105 e3p .803 e4p .092
[ ]). The obtained values do not significantly de-np 152
viate from the frequencies estimated in the normal AJ
population ( , , and fore2p .058 e3p .791 e4p .151
[Tsuda et al. 1994]; , 0.62, and 1.36,np 86 pp 0.14
respectively, corrected according to the method of
Bonferroni).
ApoE polymorphism is known to influence PLP (Hag-
berg et al. 2000). In our sample of patients with FH, no
statistically significant effect of ApoE genotype on PLP
was observed (table 5). However, in e4 carriers, baseline
TC ( mg/dl) and HDL-C ( mg/dl) are345 81 38 8
appreciably lower than those in noncarriers (380 90
and mg/dl, respectively), and this unexpected45 13
result, although devoid of statistical significance (the
sample of e4 carriers and noncarriers is small), none-
theless suggests that the reported hyperlipidemic effect
of e4 in normal subjects does not apply also to patients
with FH who have G197del. Sex was a statistically sig-
nificant factor in the determination of HDL-C levels,
with females exhibiting a constantly higher profile
( ). As has been reported elsewhere (LeitersdorfPp .012
et al. 1991), in G197del heterozygotes age is a significant
predictor of TG plasma level, with the elderly having a
level higher than that in younger individuals (Pp
). A mild age-dependent increase in TC, HDL-C,.017
and LDL-C was observed also.
There is evidence that SR-BI may affect LDL-C and
HDL-C metabolism (Acton et al. 1999). However, in
our sample of patients with FH, in no instance did SR-
BI genotype play a statistically significant role in the
determination of PLP (table 6). Again, sex was associ-
ated with a borderline statistical significance (Pp
) in the determination of HDL-C, with females ex-.049
hibiting a constantly higher level except in the subgroup
of patients who are homozygous for the common (i.e.,
wild-type) allele C.
Discussion
A highly conserved 104-208-74 haplotype—as well as
five closely related haplotypes, which vary from the for-
mer at one marker only—were identified in 86% of
G197del-bearing chromosomes of 79 unrelated families
with FH who were from five countries. This finding sug-
gests that most, if not all, G197del chromosomes derive
from a single ancestral chromosome on which the mu-
tation arose in a 104-208-74 background.
The presence of G197del chromosomes with haplo-
types differing from the conserved one at more than one
locus (14% of the families with FH who have G197del)
could be explained either by greater decay of the an-
cestral haplotype in some descent or by recurrent
G197del mutation on different haplotypes. The former
possibility would imply that the founder mutation had
existed earlier in the non-AJ populations and subse-
quently was introduced, by two or more independent
G197del chromosomes, into the AJ population, in
which it spread. Although rare, the case of a recurrent
3-bp deletion cannot be excluded. Recently, Klein et al.
(1998) reported two identical de novo GAG deletions
in the DYT1 gene; the same mutation has arisen a lim-
ited number of times throughout the centuries (Valente
et al. 1999). However, the discovery that G197del oc-
curs at a high frequency in patients with FH who are
of Lithuanian Jewish origin (Meiner et al. 1991) sug-
gests that this mutation may have originated (or been
introduced by gene flow) and subjected to earlier ex-
pansion in Lithuanian Jewry. To provide further evi-
dence for the hypothesis of a “Lithuanian mutation,”
we compared the apparent age of G197del versus the
historical and demographic data on eastern-European
Jews.
Two different methods of age estimation were used,
both of which are based on quantitative analysis of
haplotype data for LD decay over time. The first al-
gorithm (Risch et al. 1995), which neglects the contri-
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Table 6
PLP Traits According to SR-BI Genotype
PLP TRAIT
MEAN  SD CONCENTRATION (mg/dl) OF SR-BI GENOTYPE
C,C C,T T,T
TC 369.0  100.0 (n p 30) 369.9  76.0 (n p 20) 357.5  84.0 (n p 16)
TG 154.1  91.1 (n p 25) 142.4  59.6 (n p 17) 128.1  79.2 (n p 15)
HDL-C 40.1  11.7 (n p 24) 46.1  12.4 (n p 17) 44.3  14.7 (n p 15)
LDL-C 272.6  74.1 (n p 24) 299.5  78.2 (n p 17) 281.1  73.1 (n p 15)
bution of STR mutation rate to the decay of LD, re-
quires three parameters—pD, pN, and v—that are
potential sources of errors due to either sampling bias
(in the case of pD and pN) or uncertainty in the estimate
(in the case of v). Significance of LD with respect to
observed pD and pN was then assessed by estimation of
the difference in allele proportions for each marker (cor-
rected ). A critical factor in LD methods forP ! .0001
dating the age of mutations is the confidence in the v
between the disease locus and the marker: the resulting
value for g is very sensitive to fluctuations in v. Since,
because of the short (4 cM) genomic interval, the cross-
over-based genetic distances between the enlisted mark-
ers and the LDLR locus (Couture et al. 1999) are based
on a limited number of observed recombinations, v val-
ues were also conveniently derived from physical dis-
tances. However, this approach suffers from a source
of uncertainty too. The genetic-distance:physical-dis-
tance ratio is not uniform along the chromosomes, and
an average conversion factor from megabases (or cR)
to centimorgans underestimates physical distances close
to the centromeres and overestimates them in telomeric
regions (Watkins et al. 1994). Even within each region
there are remarkable differences between cytogenetic
bands, which could be responsible for gross errors in
the estimation of v. In our case, the study by Mohren-
weiser et al. (1998), which is based on the incorporation
of 180 genetic markers into the metric physical map of
human chromosome 19, provided a reliable tool for
inference of a definite conversion factor (1.9 cM/Mb)
for 19p13.1-p13.2. In addition to the three parameters
discussed above, the Markov transition-matrix method
(Reich and Goldstein 1999) requires an STR muta-
tion–rate estimate that is not free from uncertainty. In
our study, we assumed the m value given by Weber and
Wong (1993) for dinucleotide repeats (i.e., ).45.6# 10
An order-of-magnitude increase in STR mutation rate
(which is probably the case for D19S965) does not sub-
stantially change the overall three-marker estimate of
g.
The age estimates resulting from the application of
the two algorithms, which are different ways of solving
the same dynamic system, agree remarkably with each
other. This is consistent with the fact that, in our case,
v values are two orders of magnitude higher than the
average frequency of mutation at marker loci; thus, the
contribution that mutation makes to the breaking of
LD over time is comparatively very small. For dp .4
(Risch et al. 1995; Labuda et al. 1997), the Luria-Del-
bru¨ck correction of the genetic clock yields ages that
are 6–8 g older than the uncorrected estimations. How-
ever, because of the uncertainty with regard to the AJ
population growth rate (d varies from century to cen-
tury and from settlement to settlement), we preferred
to rely on the mean (i.e., 20 g) of the corrected ages
estimated by use of d interval (.1–.8) that reflects con-
servatively the available demographic data. Although
the expected coalescence time is independent of the
shape of the genealogy, CIs are strongly dependent on
the precise shape (Goldstein et al. 1999). Growing pop-
ulations produce star genealogies, which are not the
same as those assumed in the Luria-Delbru¨ck correc-
tion, which have regular internode lengths (as pointed
out by one of the anonymous reviewers of the present
article). However, even if we account for this source of
uncertainty, it is striking that the CI for the coalescence
time still includes the approximate time of foundation
of the ancestral Lithuanian Jewish community (see
below).
If it is assumed that years (Tremblay and Ve´-gp 30
zina 2000; Sigurgardottir et al. 2000) and that 1960 is
the average year of birth of the subjects enlisted in the
present study (table 1), the present results would date
the most recent common ancestor bearing G197del back
to 1360 A.D. (95%CI 1180–1510 A.D), where the CI
for the three-markers–based mean estimate relies on the
range of AJ population growth rate assumed for the
Luria-Delbru¨ck correction. Alternatively, the same co-
alescence analysis would date back to 1330 A.D. if a
median value (i.e., 21 g) for the corrected age is cal-
culated by use of the minimum CIs derived from the
variance of LD index (see the Results section
Several disease mutations present in AJ individuals can
be traced back to medieval progenitor Jewish popula-
tions; these mutations include Bloom syndrome (MIM
210900) blm(Ash), mutations associated with factor XI
deficiency (MIM 264900) type II, Gaucher disease (MIM
230800) N370S and 84GG, adenomatous polyposis of
the colon (APC [MIM 175100]) I1307K, mutations as-
sociated with familial dysautonomia (MIM 223900), the
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idiopathic torsion dystonia (MIM 128100) DYT1 GAG
deletion, and breast-ovarian cancer (MIM 113705)
BRCA1 185delAG mutations. LD analyses have sug-
gested that chromosomes bearing some of these muta-
tions identically by descent coalesced in the AJ population
around or before the 11th century (Colombo 2000, table
2; Diaz et al. 2000). This is consistent with major AJ
bottlenecks occurring during the second half of the first
millennium and the beginning of the second one, when
the population became established in Europe. Our mu-
tation-dating results suggest that the most recent com-
mon ancestor of G197del chromosomes belongs to the
first half of the second millennium—that is, the late Mid-
dle Ages—when new opportunities for a founder effect
were offered by Jewish settlers moving eastward. Despite
the methodological limits associated with LD-based age
estimation, the present results, taken together with the
ancestral Lithuanian AJ origin of most G197del chro-
mosomes, are consistent with the following historically
plausible scenario for the origin and spread of the mu-
tation. It is well known that, before the 16th century, AJ
individuals preferred to reside in small urban commu-
nities (Motulsky 1979). Early migrations of AJ individ-
uals from medieval Germany eastward could have been
encouraged by new opportunities related to the rise of
towns in the developing new states (Davies 1984). Fur-
thermore, in western Europe the life conditions for Jews
soon became unfavorable: persecutions increased during
the time of the Crusades and intensified on the occasion
of the outburst of bubonic plague (14th century), re-
sulting in the decimation of the Jewish communities. Priv-
ileges were granted to Jews in eastern countries—for ex-
ample, in Kalisz (1264), Cracow (1334), Lesser Poland
and Red Russia (1364), and Lithuania (1338). The foun-
dation of the ancestral Jewish community of Lithuania
occurred in 1338 A.D. (Ankori 1979). During the 14th
century, the G197del LDLR mutation could have been
introduced into the chromosomes of the first Lithuanian
AJ settlers by either a mutational event or gene flow. The
favorable circumstances, which led to the great demo-
graphic expansion of AJ individuals in this part of Europe
(Davies 1984; Barnavi 1992; Beirnart 1992), were pre-
sumably promoted by the establishment of the Jagiellon-
ian commonwealth (Poland, Lithuania, Ukraine, and Be-
larus) toward the end of the 14th century. The total
number of Jews living in Poland and Lithuania around
1500 A.D. is estimated to have been 10,000–12,000
(Weinryb 1972). Such a rapid population growth from
a limited number of settlers would have established a
founder effect. When Lithuania was conquered by Rus-
sian troops during the 17th century, Lithuanian AJ in-
dividuals became inhabitants of Russia. It is known that
during the following centuries practically all of St. Pe-
tersburg’s Jews came from the western territories of the
former Russian Empire settled by AJ individuals from
Lithuania and Poland (Bershadskyi 1893). Lithuanian
Jews lived in a relative cultural and environmental iso-
lation until the turn of the 19th century, when many of
them emigrated to South Africa, Great Britain, Australia,
America, and Palestine (Gar 1971). The presence of
G197del in six unrelated Jewish families with FH who
live in England (Gudnason et al. 1993) could be ex-
plained by the fact that Great Britain assisted emigration
of Jews from Tsarist Russia. Since ∼40,000 Lithuanian
immigrants came to South Africa during 1880–1910 and
gave rise to most of the local AJ population, it is not
surprising that G197del was found in 8 of 10 FH cases
in the local Jewish community (Meiner et al. 1991). The
same argument applies to Israel, where hundreds of
thousands of Jews from eastern Europe settled after the
World War II, thus introducing G197del by gene flow
from multiple independent families with FH. Therefore,
the estimated age of the G197del LDLR mutation, the
origin and geographic distribution of families with FH,
and the history of eastern-European AJ individuals are
consistent with the hypothesis that the mutation origi-
nated (or was originally introduced) and has been sub-
jected to earlier expansion in Lithuania.
The high frequencies of certain single-locus genetic
diseases in the AJ population has long been a subject
of interest (Goodman and Motulsky 1979). However,
the underlying genetic mechanism(s) accounting for
their elevated prevalence remains controversial. Some
authors have attributed this epidemiological figure to
the demographic upheavals thought to have occurred
during or shortly after the 16th and 17th centuries: the
founder effect resulted from the AJ population’s ex-
traordinary growth after a fortuitous introduction of
disease alleles into a relatively small group of individuals
from whom present-day the AJ individuals have de-
scended (Risch et al. 1995). Other investigators have
suggested that a heterozygote selective advantage has
been the operative genetic mechanism (Myrianthopou-
los et al. 1972; Petersen et al. 1983; Diamond 1994;
Zoossmann-Diskin 1995). For Tay-Sachs (MIM
272800) and other recessive lysosomal storage disor-
ders, it has been speculated that heterozygotes may have
an increased resistance to some infectious diseases—for
example, tuberculosis. Although this suggestion is at-
tractive and although some geographic distributions of
allele frequencies appear to support, in part, the argu-
ment of positive selection, a clear biological benefit of
heterozygosity for these (Jorde 1992) and other (Ho¨-
genauer et al. 2000) mutations is difficult to document.
Genetic drift in a population ancestral to AJ individuals
remains a third possibility (Goldstein et al. 1999), and
the recent finding that a common N370S allele, causing
Gaucher disease type 1, is concurrently present in the
AJ population and in the neighboring non-Jewish Eu-
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ropean populations allows some inferences to be drawn
(Diaz et al. 2000).
For diseases in the AJ population, the study of the
origin and spread of an autosomal dominant mutation
offers an advantage over the investigation of recessive
disorders such as Tay-Sachs disease or Gaucher disease.
The distinct opportunity derives from the consideration
that heterozygote selective advantage does not operate
in this case: dominant pathological mutations are sub-
ject to direct selection over disease phenotype. This op-
portunity has been exploited already by Risch et al.
(1995), who studied the DYTAJ mutation causing idi-
opathic torsion dystonia in AJ individuals. Unfortu-
nately, the DYTAJ model is complicated by the highly
variable expression of the gene, since only a small pro-
portion of carriers manifest a severe form of the disease.
If both mild and severe cases are included, the overall
penetrance is ∼30% (Bressman et al. 1989; Risch et al.
1990). According to Risch et al. (1995, p. 156), “per-
haps only a third of those with clinical symptoms would
be categorized as severely affected,” and only “severely
affected individuals tend not to reproduce.” Other au-
tosomal dominant AJ diseases—for example, BRCA1,
BRCA2, and APC—show reduced penetrance as well.
The G197del LDLR mutation causes clinically man-
ifested FH both in heteroallelic status and in homoallelic
status (although the latter is rare—our Piscataway index
case is the only patient described so far), and its bio-
chemical phenotype is easily quantifiable. Ninety-four
percent of the heterozygotes ( ) in our G197del-np 98
FH register (i.e., index cases and their G197del-positive
family members) were hypercholesterolemic (LDL-C
1160 mg/dl), and there is no significant difference in
the mean PLP of patients with FH who have G197del
and are from the three main countries of residence (Is-
rael, South Africa, and Russia), whose geographic char-
acteristics, dietary habits, and lifestyles are remarkably
different. These findings are consistent with a disease
mutation with both a high degree of penetrance and
independence of major environmental effects. This is
not always the case for LDLR mutations causing FH
(Moorjani et al. 1993; Bertolini et al. 2000). We have
no clear-cut explanation of the discrepancy between our
results and those of the study by Pimstone et al. (1998),
who compared PLPs in Chinese subjects with FH and
defined LDLR mutations who were living in China and
Canada. Higher LDL-C levels, apparently not linked to
a different functional class of LDLR mutations, were
observed in FH heterozygotes residing in Canada than
were seen in FH heterozygotes living in China. These
differences were ascribed, at least in part, to the striking
contrast, both in dietary lipids and in physical-exercise
level, between the two groups of patients.
The frequency distribution of ApoE alleles e2–e4 in
our sample of G197del carriers was similar to that
found in the general AJ population (Tsuda et al. 1994).
This observation confirms the lack of difference in ApoE
allele distribution among patients with FH from Europe
and North America who have been reported elsewhere
(O’Malley and Illingworth 1990; De Knijff et al. 1990;
Dallongeville et al. 1991; Carmena-Ramo´n et al. 2000).
By contrast, Eto et al. (1988) described a higher fre-
quency of e4 in Japanese patients with FH, which may
reflect specific genetic differences between Asian and
white population samples with FH. The lack of asso-
ciation between ApoE polymorphism and G197del is
consistent both with the genetic distance between ApoE
and the LDLR locus (45 cM) and with the hypothesis
that the founder mutation arose on the most common
haplotype (i.e., e3) in the AJ population. The effect of
ApoE genotype on basal plasma-lipid levels has been
studied in different populations. In some studies of sub-
jects without FH, e4 carriers showed the highest plasma
TC and LDL-C levels, whereas lowest levels were found
in e2 carriers (reviewed in Hagberg et al. 2000). Our
results suggest that ApoE polymorphism does not sig-
nificantly contribute to variations in plasma baseline TC
or LDL-C in patients who are heterozygous for
G197del. The lack of statistical significance is likely due
to the small sample of ApoE subgroups. Our finding is
in contrast with those of Eto et al. (1988) in Japan,
Ward et al. (1996) in northern Ireland, and Bertolini et
al. (2000) in Italy, who found, among e4 carriers, sig-
nificantly higher plasma levels in individuals who are
heterozygous for FH, but it is consistent with those of
Carmena-Ramo´n et al. (2000) in Spain and other in-
vestigators in Europe and North America, including a
study of 112 unrelated French Canadian FH hetero-
zygotes with a class I (null allele) 10-kb deletion in the
LDLR 5′ region (Be´tard et al. 1996). Taken together
with the absence of evidence for significant country-
dependent difference in FH baseline PLPs (our data) and
the observation that, in contrast to subjects without FH,
in patients with FH the individual response to changes
in dietary lipids is not affected by their ApoE genotype
(Carmena-Ramo´n et al. 2000), the results of the present
study are consistent with the hypothesis that the impact
of severe mutations at the LDLR locus could prevail
over genetic factors and genetically modified response
to environmental changes. This is true also for the SR-
BI polymorphism, which does not appear to modify
plasma LDL-C levels in our sample of patients with FH.
The present study cannot be considered in any sense a
systematic screen for genetic modifiers of the biochem-
ical effect of G197del; further investigations should shed
light on whether the “right modifiers” exist. We may
therefore conclude that both the environmental factors
and the candidate modifying genes analyzed in the pre-
sent study do not affect to a significant extent the phe-
notypic expression of G197del FH, which appears to
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be a severe, highly penetrant inherited disease in AJ
individuals. Nevertheless, we cannot exclude the pos-
sibility that the G197del LDLR mutation and other
common mutations in AJ individuals may be endowed
with some selective advantage that is not linked to
known functions of the expressed proteins; however, so
far, this remains, in practice, an unverifiable speculation.
Taken as a whole, the evidence presented in this and
other studies suggests that heterozygote advantage is not
essential for a mutation to cause elevated disease inci-
dence among contemporary AJ individuals. The evi-
dence also strengthens the importance of consideration
of the founder effect in a population rapidly expanding
from a limited number of families, as a simple, parsi-
monious hypothesis to explain the spread of recent mu-
tations in the AJ population. However, the role of pos-
itive selection due to some heterozygote advantages or
genetic factors modifying the response of a mutation’s
carriers to historical or local environmental constraints
cannot be generally dismissed without proof.
Acknowledgments
This study was supported by a grant from the Sarah and
Moshe Mayer Research Foundation (to E.L.). We thank Helen
H. Hobbs (Dallas) for having supplied the DNA sample from
the patient homozygous for FH, as well as for insightful com-
ments on the manuscript, and we thank Angelo A. Bignamini
(Milan) for advice regarding statistical analysis.
Electronic-Database Information
Accession numbers and URLs for data in this article are as
follows:
GeneMap’99, http://www.ncbi.nlm.nih.gov/genemap99 (for
radiation-hybrid distance)
Genome Database, The, http://www.gdb.org (for D19S221
[accession number 188431], D19S865 [accession number
602894], and D19S413 [accession number 199839])
LDLR Database, http://www.umd.necker.fr/LDLR/database
.html (for LDLR mutations)
Low Density Lipoprotein Receptor (LDLR) Gene in Familial
Hypercholesterolemia, The, http://www.ucl.ac.uk/fh (for
LDLR mutations)
Maps of Human Chromosome 19, http://bbrp.llnl.gov/bbrp/
genome/html/chrom_map.html (for v values)
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim/ (for FH [MIM 143890], Tay-
Sachs disease [MIM 272800], Gaucher disease [MIM
230800], idiopathic torsion dystonia [MIM 128100], breast
cancer types 1 [MIM 113705] and 2 [MIM 600185], APC
[MIM 175100], Bloom syndrome [MIM 210900], factor XI
deficiency [MIM 264900], and familial dysautonomia [MIM
223900])
References
Aalto-Setala K, Koivisto U-M, Miettinen TA, Gylling H, Kes-
aniemi YA, Savolainen M, Pyorala K, Ebeling T, Mononen
I, Turtola H, Viikari J, Kontula K (1992) Prevalence and
geographical distribution of major LDL receptor gene re-
arrangements in Finland. J Intern Med 231:227–234
Acton S, Osgood D, Donoghue M, Corella D, Pocovi M, Cen-
arro A, Mozas P, Keitly J, Squazzo S, Woolf EA, Ordovas
JM (1999) Association of polymorphisms at the SR-BI gene
locus with plasma lipid levels and body mass index in a
White population. Arterioscler Thromb Vasc Biol 19:
1734–1743
Ankori Z (1979) Origins and history of Ashkenazi Jewry (8th
to 18th century). In: Goodman RM, Motulsky AG (eds)
Genetic diseases among Ashkenazi Jews. Raven Press, New
York, pp 19–46
Barnavi E (ed) (1992) A historical atlas of the Jewish people.
Schocken Books, New York
Beirnart H (1992) Atlas of medieval Jewish history, Simon &
Schuster, New York
Bengtsson BO, Thomson G (1981) Measuring the strength of
associations between HLA antigens and diseases. Tissue An-
tigens 18:356–363
Bershadskyi S (1893) Jews in Lithuania. In: Arsenjev KK, Pe-
trovski FF (eds) Encyclopedic dictionary (in Russian). Vol
11. Brockhaus-Efron, St Petersburg, pp 453–454
Bertolini S, Cantafora A, Averna M, Cortese C, Motti C, Mar-
tini S, Pes G, Postiglione A, Stefanutti C, Blotta I, Pisciotta
L, Rolleri M, Langheim S, Ghisellini M, Rabbone I, Cal-
andra S (2000) Clinical expression of familial hypercholes-
terolemia in clusters of mutations of the LDL receptor gene
that cause a receptor-defective or receptor-negative pheno-
type. Arterioscler Thromb Vasc Biol 20:E41–E52
Be´tard C, Kessling AM, Roy M, Davignon J (1996) Influence
of genetic variability in the nondeletion LDL-receptor allele
on phenotypic variation in French-Canadian familial hy-
percholesterolemia heterozygotes sharing a ‘null’ LDL-re-
ceptor gene defect. Atherosclerosis 119:43–55
Bressman SB, de Leon D, Brin MF, Risch N, Burke RE, Greene
PE, Shale H, Fahn S (1989) Idiopathic dystonia among Ash-
kenazi Jews: evidence for autosomal dominant inheritance.
Ann Neurol 26:612–620
Carmena-Ramo´n R, Real JT, Ascaso JF, Ordovas JM, Carmena
R (2000) Effect of apolipoprotein E genotype on lipid levels
and response to diet in familial hypercholesterolemia. Nutr
Metab Cardiovasc Dis 10:7–13
Colombo R (2000) Age estimate of the N370S mutation caus-
ing Gaucher disease in Ashkenazi Jews and European pop-
ulations: a reappraisal of haplotype data. Am J Hum Genet
66:692–697
Colombo R, Carobene A (2000) Age of the intronic GAA
triplet repeat expansion mutation in Friedreich ataxia. Hum
Genet 106:455–458
Couture P, Morissette J, Gaudet D, Vohl M-C, Gagne´ C, Ber-
geron J, Despre´s J-P, Simard J (1999) Fine mapping of low-
density lipoprotein receptor gene by genetic linkage on chro-
mosome 19p13.1-p13.3 and study of the founder effect of
four French Canadian low-density lipoprotein receptor gene
mutations. Atherosclerosis 143:145–151
1186 Am. J. Hum. Genet. 68:1172–1188, 2001
Dallongeville J, Roy M, Leboeuf N, Xhignesse M, Davignon
J, Lussier-Cacan S (1991) Apolipoprotein E polymorphism
association with lipoprotein profile in endogenous hyper-
triglyceridemia and familial hypercholesterolemia. Arterios-
cler Thromb 11:272–278
Daniel WW (1995) Biostatistics: a foundation for analysis in
the health sciences, 6th ed. Wiley & Sons, New York, pp
139–140, 175
Davies N (1984) God’s playground: a history of Poland. Co-
lumbia University Press, New York
De Knijff P, Stalenhoef AF, Mol MJ, Gevers Leuven JA, Smit
J, Erkelens DW, Schouten J, Frants RR, Havekes LM (1990)
Influence of apo E polymorphism on the response to sim-
vastatin treatment in patients with heterozygous familial hy-
percholesterolemia. Atherosclerosis 83:89–97
Diamond JM (1994) Jewish lysosomes. Nature 368:291–292
Diaz GA, Gelb BD, Risch N, Nygaard TG, Frisch A, Cohen
IJ, Miranda CS, Amaral O, Maire I, Poenaru L, Caillaud C,
Weizberg M, Mistry P, Desnick RJ (2000) Gaucher disease:
the origins of the Ashkenazi Jewish N370S and 84GG acid
b-glucosidase mutations. Am J Hum Genet 66:1821–1832
Eto M, Watanabe K, Chonan N, Ishii K (1988) Familial hy-
percholesterolemia and apolipoprotein E4. Atherosclerosis
72:123–128
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation
of the concentration of low-density lipoprotein cholesterol
in plasma, without use of the preparative ultracentrifuge.
Clin Chem 18:499–502
Gar J (1971) Lithuania. In: Berman MM, Carlebach (eds) Ju-
daica encyclopedia. Keter, Jerusalem, pp 362–390
Geisel J, Holzem G, Oette K (1995) Screening for mutations
in exon 4 of the LDL receptor gene in a German population
with severe hypercholesterolemia. Hum Genet 96:301–304
Goldstein DB, Pollock DD (1997) Launching microsatellites:
a review of mutation process and methods of phylogenetic
inference. J Hered 88:335–342
Goldstein DB, Reich ED, Bradman N, Usher S, Seligsohn U,
Peretz H (1999) Age estimates of two common mutations
causing factor XI deficiency: recent genetic drift is not nec-
essary for elevated disease incidence among Ashkenazi Jews.
Am J Hum Genet 64:1071–1075
Goldstein JL, Brown MS, Anderson RGW, Russell DW, Schnei-
der WJ (1985) Receptor-mediated endocytosis: concepts
emerging from the LDL receptor system. Annu Rev Cell Biol
1:1–39
Goldstein JL, Hobbs HH, Brown MS (1995) Familial hyper-
cholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle
D (eds) The metabolic and molecular bases of inherited dis-
ease, 7th ed. McGraw-Hill, New York, pp 1981–2030
Goodman RM, Motulsky A (eds) (1979) Genetic diseases
among Ashkenazi Jews. Raven Press, New York
Gudnason V, King-Underwood L, Seed M, Sun X-M, Soutar
AK, Humphries SE (1993) Identification of recurrent and
novel mutations in exon 4 of LDL receptor gene in patients
with familial hypercholesterolemia in the United Kingdom.
Arterioscler Thromb 13:56–63
Guo S-W, Xiong M (1997) Estimating the age of mutant dis-
ease alleles based on linkage disequilibrium. Hum Hered 47:
315–337
Hagberg JM, Wilund KR, Ferrell RE (2000) APO E gene and
gene-environment effects on plasma lipoprotein-lipid levels.
Physiol Genomics 4:101–108
Ha¨stbacka J, de la Chapelle A, Kaitila I, Sistonen P, Weaver
A, Lander E (1992) Linkage disequilibrium mapping in iso-
lated founder populations: diastrophic dysplasia in Finland.
Nat Genet 2:204–211
Heath KE, Gahan M, Whittall RA, Humphries SE (2001) Low-
density lipoprotein receptor gene (LDLR) world-wide web-
site in familial hypercholesterolaemia: update, new features
and mutation analysis. Atherosclerosis 154:243–246
Hixson JE, Vernier DT (1990) Restriction isotyping of human
apolipoprotein E by gene amplification and cleavage with
HhaI. J lipid Res 31:545–548
Hobbs HH, Russell DW, Brown MS, Goldstein JL (1990) The
LDL receptor locus in familial hypercholesterolemia: mu-
tational analysis of a membrane protein. Annu Rev Genet
24:133–170
Ho¨genauer C, Santa Ana CA, Porter JL, Millard M, Gelfand
A, Rosenblatt RL, Prestidge CB, Fordtran JS (2000) Active
intestinal chloride secretion in human carriers of cystic fi-
brosis mutations: an evaluation of the hypothesis that het-
erozygotes have subnormal active intestinal chloride secre-
tion. Am J Hum Genet 67:1422–1427
Iwaki K, Nakajima T, Ota N, Emi M (1999) A common
Ile796Val polymorphism of the human SREBP cleavage-ac-
tivating protein (SCAP) gene. J Hum Genet 44:421–422
Jorde LB (1992) Genetic diseases in the Ashkenazi population:
evolutionary considerations. In: Bonne´-Tamir B, Adam A
(eds) Genetic diversity among Jews: diseases and markers at
the DNA level. Oxford University Press, New York, pp
305–318
Kaplan NL, Hill WG, Weir BS (1995) Likelihood methods for
locating disease genes in nonequilibrium populations. Am J
Hum Genet 56:18–32
Klein C, Brin MF, de Leon D, Limborska SA, Ivanova-Smo-
lenskaya IA, Bressman SB, Fiedman A, Markova ED, Risch
NJ, Breakefield XO, Ozelius LJ (1998) De novo mutations
(GAG deletion) in the DYT1 gene in two non-Jewish patients
with early-onset dystonia. Hum Mol Genet 7:1133–1136
Koivisto U-M, Turtola H, Aalto-Setala K, Top B, Frants RR,
Kovanen PT, Syvanen A-C, Kontula K (1992) The familial
hypercholesterolemia (FH)-North Karelia mutation of the
low density lipoprotein receptor gene deletes seven nucle-
otides of exon 6 and is a common cause of FH in Finland.
J Clin Invest 90:219–228
Kotze MJ, Langenhoven E, Warnich L, du Plessis L, Retief AE
(1991) The molecular basis and diagnosis of familial hy-
percholesterolaemia in South African Afrikaners. Ann Hum
Genet 55:115–121
Labuda M, Labuda D, Korab-Laskowska M, Cole DE, Ziet-
kiewicz E, Weissenbach J, Popowska E, Pronicka E, Root
AW, Glorieux FH (1996) Linkage disequilibrium analysis in
young populations: pseudo-vitamin D-deficiency rickets and
the founder effect in French Canadians. Am J Hum Genet
59:633–643
Labuda D, Zietkiewicz, Labuda M (1997) The genetic clock
and the age of the founder effect in growing populations: a
lesson from French Canadians and Ashkenazim. Am J Hum
Genet 61:768–771
Landsberger D, Meiner V, Reshef A, Levy Y, van der Wes-
Durst et al.: G197del LDLR in Ashkenazi Jews 1187
thuyzen DR, Coetzee GA, Leitersdorf E (1992) A nonsense
mutation in the LDL receptor gene leads to familial hyper-
cholesterolemia in the Druze sect. Am J Hum Genet 50:
427–433
Lazzeroni LC (1998) Linkage disequilibrium and gene map-
ping: an empirical least-squares approach. Am J Hum Genet
62:159–170
Lehesjoki AE, Koskiniemi M, Norio R, Tirrito S, Sistonen P,
Lander E, de la Chapelle A (1993) Localization of the EPM1
gene for progressive myoclonus epilepsy on chromosome 21:
linkage disequilibrium allows high resolution mapping.
Hum Mol Genet 2:1229–1234
Lehrman MA, Schneider WJ, Brown MS, Davis CG, Elhammer
A, Russell DW, Goldstein JL (1987) The Lebanese allele at
the low density lipoprotein receptor locus: nonsense muta-
tion produces truncated receptor that is retained in endo-
plasmic reticulum. J Biol Chem 262:401–410
Leitersdorf E, Friedlander Y, Bard JM, Fruchart JC, Eisenberg
S, Stein Y (1991) Diverse effect of ethnicity on plasma li-
poprotein[a] levels in heterozygote patients with familial hy-
percholesterolemia. J Lipid Res 32:1513–1519
Leitersdorf E, Tobin EJ, Davignon J, Hobbs, HH (1990) Com-
mon low-density lipoprotein receptor mutations in the
French Canadian population. J Clin Invest 85:1014–1023
Loubser O, Marais AD, Kotze MJ, Godenir N, Thiart R, Scoltz
CL, de Villiers JN, Hillermann R, Firth JC, Weich HF, Maritz
F, Jones S, van der Westhuyzen DR (1999) Founder muta-
tions in the LDL receptor gene contribute significantly to
the familial hypercholesterolemia phenotype in the indige-
nous South African population of mixed ancestry. Clin Ge-
net 55:340–345
Luria SE, Delbru¨ck M (1943) Mutations of bacteria from virus
sensitivity to virus resistance. Genetics 28:491–511
Mandelshtam M, Chakir K, Shevtsov S, Golubkov V, Sko-
beleva N, Lipovetsky B, Konstantinov V, Denisenko A, Gait-
skhoki V Schwartz E (1998) Prevalence of Lithuanian mu-
tation among St. Petersburg Jews with familial
hypercholesterolemia. Hum Mutat 12:255–258
Meiner V, Landsberger D, Berkman N, Reshef A, Segal P, Seftel
HC, van der Westhuyzen DR, Jeenah MS, Coetzee GA, Lei-
tersdorf E (1991) A common Lithuanian mutation causing
familial hypercholesterolemia in Ashkenazi Jews. Am J Hum
Genet 49:443–449
Mohrenweiser HW, Tsujimoto S, Gordon L, Olsen AS (1998)
Regions of sex-specific hypo- and hyper-recombination iden-
tified through integration of 180 genetic markers into the
metric physical map of human chromosome 19. Genomics
47:153–162
Moorjani S, Roy M, Gagne´ C, Davignon J, Brun D, Toussaint
M, Lambert M, Campeau L, Blaichman S, Lupien P (1989)
Homozygous familial hypercholesterolemia among French
Canadians in Que´bec province. Arteriosclerosis 9:211–216
Moorjani S, Roy M, Torres A, Betard C, Gagne C, Lambert
M, Brun D, Davignon J, Lupien P (1993) Mutations of low-
density-lipoprotein-receptor gene, variation in plasma cho-
lesterol, and expression of coronary heart disease in ho-
mozygous familial hypercholesterolaemia. Lancet 341:
1303–1306
Motulsky AG (1979) Possible selective effects of urbanization
on Ashkenazi Jews. In: Goodman RM, Motulsky AG (eds)
Genetic diseases among Ashkenazi Jews. Raven Press, New
York, pp 301–312
Myrianthopoulos NC, Naylor AF, Aronson SM (1972) Foun-
der effect in Tay-Sachs disease unlikely. Am J Hum Genet
24:341–342
O’Malley JP, Illingworth DR (1990) The influence of apoli-
poprotein E phenotype on the response to lovastatin therapy
in patients with heterozygous familial hypercholesterolemia.
Metabolism 39:150–154
Petersen GM, Rotter JI, Cantor RM, Field LL, Grenwald S,
Lim JS, Roy C, Schoenfeld V, Lowden JA, Kaback MM
(1983) The Tay-Sachs disease gene in North American Jew-
ish populations: geographic variations and origin. Am J
Hum Genet 35:1258–1269
Pimstone SN, Sun XM, du Souich C, Frohlich JJ, Hayden MR,
Soutar AK (1998) Phenotypic variation in heterozygous fa-
milial hypercholesterolemia: a comparison of Chinese pa-
tients with the same or similar mutations in the LDL receptor
gene in China or Canada. Arterioscler Thromb Vasc Biol
18:309–315
Rannala B, Slatkin M (1998) Likelihood analysis of disequi-
librium mapping and related problems. Am J Hum Genet
62:459–473
Reich DE, Goldstein DB (1999) Estimating the age of muta-
tions using variation at linked markers. In: Goldstein GB,
Schlo¨tterer C (eds) Microsatellites: evolution and applica-
tions. Oxford University Press, Oxford, pp 129–138
Risch N, Bressman SB, deLeon D, Brin MF, Burke RE, Greene
PE, Shale H, Claus EB, Cupples LA, Fahn S (1990) Segre-
gation analysis of idiopathic torsion dystonia in Ashkenazi
Jews suggests autosomal dominant inheritance. Am J Hum
Genet 46:533–538
Risch N, de Leon D, Ozelius L, Kramer P, Almasy L, Singer
B, Fahn S, Breakefield X, Bressman S (1995) Genetic analysis
of idiopathic torsion dystonia in Ashkenazi Jews and their
recent descent from a small founder population. Nat Genet
9:152–159
Seftel HC, Baker SG, Jenkins T, Mendelson D (1989) Preva-
lence of familial hypercholesterolemia in Johannesburg
Jews. Am J Med Genet 34:545–547
Sigurgardottir S, Helgason A, Gulcher JR, Stefansson K, Don-
nelly P (2000) The mutation rate in the human mtDNA
control region. Am J Hum Genet 66:1599–1609
Slimane MN, Pousse H, Maatoug F, Hammami M, Ben-Farhat
MH (1993) Phenotypic expression of familial hypercholes-
terolaemia in central and southern Tunisia. Atherosclerosis
104:153–158
Steyn K, Weight MJ, Dando BR, Christopher KJ, Rossouw JE
(1989) The use of low density lipoprotein receptor activity
of lymphocytes to determine the prevalence of familial hy-
percholesterolemia in a rural South African community. J
Med Genet 26:32–36
Su¨dhof TC, Goldstein JL, Brown MS, Russell DW (1985) The
LDL receptor gene: a mosaic of exons shared with different
proteins. Science 228:815–822
Tremblay M, Ve´zina H (2000) New estimates of intergener-
ational time intervals for the calculation of age of origins
of mutations. Am J Hum Genet 66:651–658
Tsuda T, Lopez R, Rogaeva EA, Freedman M, Rogaev E,
Drachman D, Pollen D, Haines J, Liang Y, McLachlan DR,
1188 Am. J. Hum. Genet. 68:1172–1188, 2001
Duara R, St George-Hyslop P (1994) Are the associations
between Alzheimer’s disease and polymorphisms in the apo-
lipoprotein E and the apolipoprotein CII genes due to link-
age disequilibrium? Ann Neurol 36:97–100
Valente EM, Povey S, Warner TT, Wood NW, Davis MB (1999)
Detailed haplotype analysis in Ashkenazi Jewish and non-
Jewish British dystonic patients carrying the GAG deletion
in the DYT1 gene: evidence for a limited number of founder
mutations. Ann Hum Genet 63:1–8
Varret M, Rabes J-P, Thiart R, Kotze J, Baron H, Cenarro A,
Descamps O, Ebhart M, Hondelijn J-C, Kostner GM, Mi-
yake Y, Pocovi M, Schmidt H, Schmidt H, Schuster H, Stuhr-
mann M, Yamamura T, Junien C, Be´roud C, Boileau C
(1998) LDLR database (second edition): new additions to
the database and the software, and results of the first mo-
lecular analysis. Nucleic Acids Res 26:248–252
Ward AJ, O’Kane M, Nicholls DP, Young IS, Nevin NC, Gra-
ham CA (1996) A novel single base deletion in the LDLR
gene (311delG): effect on serum lipid profiles and the influ-
ence of other genetic polymorphisms in the ACE, APOE and
APOB genes. Atherosclerosis 120:83–91
Watkins WS, Zenger R, O’Brien E, Nyman D, Eriksson AW,
Renlund M, Jorde B (1994) Linkage disequilibrium patterns
vary with chromosomal location: a case study from the von
Willebrand factor region. Am J Hum Genet 55:348–355
Weber JL, Wong C (1993) Mutation of human short tandem
repeats. Hum Mol Genet 2:1123–1128
Weinryb BD (1972) The Jews of Poland: a social and economic
history of the Jewish community in Poland from 1100 to
1800. Jewish Publication Society of America, Philadelphia
Zoossmann-Diskin A (1995) ITD in Ashkenazi Jews: genetic
drift or selection? Nat Genet 11:13–14
